Healthcare provider profile · identity verified

Louisa J Hann, MD

Family Practice · CHARLOTTESVILLE, VA · NPI 1508960972

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	426	121
Amlodipine Besylate	Amlodipine Besylate	264	82
Lisinopril	Lisinopril	243	79
Levothyroxine Sodium	Levothyroxine Sodium	240	69
Losartan Potassium	Losartan Potassium	196	60
Gabapentin	Gabapentin	162	60
Rosuvastatin Calcium	Rosuvastatin Calcium	161	52
Metformin Hcl Er	Metformin Hcl	145	44
Alendronate Sodium	Alendronate Sodium	133	42
Pravastatin Sodium	Pravastatin Sodium	132	39
Hydrochlorothiazide	Hydrochlorothiazide	130	38
Omeprazole	Omeprazole	120	39
Metoprolol Succinate	Metoprolol Succinate	98	33
Escitalopram Oxalate	Escitalopram Oxalate	96	30
Simvastatin	Simvastatin	80	28
Eliquis	Apixaban	72	14
Fluticasone Propionate	Fluticasone Propionate	71	21
Albuterol Sulfate Hfa	Albuterol Sulfate	70	33
Duloxetine Hcl	Duloxetine Hcl	62	19
Trazodone Hcl	Trazodone Hcl	61	23
Montelukast Sodium	Montelukast Sodium	60	19
Citalopram Hbr	Citalopram Hydrobromide	59	17
Furosemide	Furosemide	59	18
Pantoprazole Sodium	Pantoprazole Sodium	55	19
Sertraline Hcl	Sertraline Hcl	55	18
Carvedilol	Carvedilol	53	11
Synthroid	Levothyroxine Sodium	53	13
Allopurinol	Allopurinol	51	14
Ozempic	Semaglutide	51	suppressed
Bupropion Xl	Bupropion Hcl	49	15
Lorazepam	Lorazepam	48	20
Potassium Chloride	Potassium Chloride	43	13
Clonazepam	Clonazepam	42	11
Diclofenac Sodium	Diclofenac Sodium	38	suppressed
Metformin Hcl	Metformin Hcl	38	14
Buspirone Hcl	Buspirone Hcl	36	15
Metoprolol Tartrate	Metoprolol Tartrate	36	suppressed
Prednisone	Prednisone	35	30
Fluoxetine Hcl	Fluoxetine Hcl	34	13
Doxycycline Hyclate	Doxycycline Hyclate	33	31
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	32	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	32	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	32	14
Tamsulosin Hcl	Tamsulosin Hcl	30	13
Alprazolam	Alprazolam	28	13
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	28	suppressed
Famotidine	Famotidine	27	13
Tizanidine Hcl	Tizanidine Hcl	27	11
Triamcinolone Acetonide	Triamcinolone Acetonide	27	14
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	25	suppressed
Fluconazole	Fluconazole	24	12
Bupropion Hcl Sr	Bupropion Hcl	23	suppressed
Clopidogrel	Clopidogrel Bisulfate	23	suppressed
Ipratropium Bromide	Ipratropium Bromide	23	suppressed
Valacyclovir	Valacyclovir Hcl	23	15
Oxycodone Hcl	Oxycodone Hcl	22	suppressed
Cephalexin	Cephalexin	21	15
Glipizide Er	Glipizide	21	suppressed
Ondansetron Odt	Ondansetron	21	16
Spironolactone	Spironolactone	21	suppressed
Sumatriptan Succinate	Sumatriptan Succinate	21	suppressed
Tramadol Hcl	Tramadol Hcl	21	11
Atenolol	Atenolol	20	suppressed
Lovastatin	Lovastatin	20	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	19	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	18	16
Baclofen	Baclofen	18	11
Estradiol	Estradiol	18	11
Nystatin	Nystatin	18	suppressed
Breo Ellipta	Fluticasone/Vilanterol	17	suppressed
Mounjaro	Tirzepatide	17	suppressed
Mupirocin	Mupirocin	17	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	17	12
Olmesartan Medoxomil	Olmesartan Medoxomil	17	suppressed
Memantine Hcl	Memantine Hcl	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	15	suppressed
Chlorthalidone	Chlorthalidone	13	suppressed
Diazepam	Diazepam	13	suppressed
Klor-Con M20	Potassium Chloride	13	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	13	suppressed
Nifedipine Er	Nifedipine	13	suppressed
Torsemide	Torsemide	13	suppressed
Valsartan	Valsartan	13	suppressed
Ezetimibe	Ezetimibe	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Meloxicam	Meloxicam	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Paxlovid	Nirmatrelvir/Ritonavir	12	12
Wellbutrin Xl	Bupropion Hcl	12	suppressed
Propranolol Hcl Er	Propranolol Hcl	11	suppressed
Trulicity	Dulaglutide	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error